|

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

RECRUITINGSponsored by Herlev and Gentofte Hospital
Actively Recruiting
SponsorHerlev and Gentofte Hospital
Started2015-01-01
Est. completion2030-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05184400

Summary

No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histological or cytological diagnosis of BTC
* Patients referred for treatment of BTC
* Signed informed consent

Exclusion Criteria:

* None

Conditions4

Biliary Tract CancerCancerCholangiocarcinomaGallbladder Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.